Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.
Many diabetic patients continue to have hyperglycaemia on maximal sulphonylurea therapy. Five different therapeutic options, with the prime aim of achieving normal fasting plasma glucose concentrations, have been compared in 15 asymptomatic, sulphonylurea-treated type 2 diabetic patients in a random...
Auteurs principaux: | Holman, R, Steemson, J, Turner, R |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
1987
|
Documents similaires
-
TWICE-DAILY SUBCUTANEOUS HUMAN PROINSULIN PROVIDES A SATISFACTORY BASAL INSULIN SUPPLEMENT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
par: Holman, R, et autres
Publié: (1987) -
Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM
par: Rachman, J, et autres
Publié: (1996) -
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
par: Matthews, DR, et autres
Publié: (1998) -
UKPDS 18: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy
par: Eeley, E, et autres
Publié: (1996) -
COMPARISON OF TREATMENT OF MILD DIABETES WITH A BASAL INSULIN SUPPLEMENT OR SULFONYLUREA
par: Holman, R, et autres
Publié: (1977)